Towards a Transparent, Credible, Evidence-Based Decision-Making Process of New Drug Listing on the Hong Kong Hospital Authority Drug Formulary: Challenges and Suggestions-Reference-Cited by-同舟云学术

Towards a Transparent, Credible, Evidence-Based Decision-Making Process of New Drug Listing on the Hong Kong Hospital Authority Drug Formulary: Challenges and Suggestions

Published:2017-07-12 Issue:1 Volume:16 Page:5-14
ISSN:1175-5652
Container-title:Applied Health Economics and Health Policy
language:en
Short-container-title:Appl Health Econ Health Policy

Author:

Wong Carlos King Ho^ORCID,Wu Olivia^ORCID,Cheung Bernard M. Y.^ORCID

Funder

Glasgow/HKU Early Career Mobility Fund

Publisher

Springer Science and Business Media LLC

Subject

Health Policy,Economics and Econometrics,General Medicine

Link

http://link.springer.com/article/10.1007/s40258-017-0339-5/fulltext.html

Reference38 articles.

1. Morgan SG, McMahon M, Mitton C, Roughead E, Kirk R, Kanavos P, et al. Centralized drug review processes in Australia, Canada, New Zealand, and the United Kingdom. Health Aff. 2006;25(2):337–47.

2. National Institute for Health and Care Excellence. Guide to the methods of technology appraisal 2013. London: NICE; 2013.

3. Scottish Medicines Consortium. Submission guidance and templates for submission. Available from: https://www.scottishmedicines.org.uk/Submission_Process/Submission_guidance_and_forms . Accessed 29 Nov 2016.

4. Australian Government Department of Health. Procedure guidance for listing medicines on the Pharmaceutical Benefits Scheme. 2016. Available from: http://www.pbs.gov.au/industry/listing/procedure-guidance-listing-medicines-pbs/files/procedure-guidance-listing-medicines-on-the-pbs.pdf .

5. CADTH Common Drug Review. Procedure for the CADTH Common Drug Review. 2014. Available from: https://www.cadth.ca/sites/default/files/cdr/process/Procedure_for_CADTH_CDR.pdf . Accessed 29 Nov 2016.

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Bridging Real-World Data Gaps: Connecting Dots Across 10 Asian Countries;JMIR Medical Informatics;2024-08-15

2. Bridging Real-World Data Gaps: Connecting Dots Across 10 Asian Countries (Preprint);2024-03-18

3. Cost Effectiveness of PD-L1-Based Test-and-Treat Strategy with Pembrolizumab as the First-Line Treatment for Metastatic NSCLC in Hong Kong;PharmacoEconomics - Open;2019-09-17

4. Budget impact of introducing tofacitinib to the public hospital formulary in Hong Kong, 2017-2021;Hong Kong Medical Journal;2019-05-29